Strides Pharma to acquire arms of Endo in U.S for $24 mn
The Hindu
With this acquisition, Strides would have doubled its US portfolio with the potential to launch 5-6 new products each quarter going forward.
City-based Strides Pharma Science Limited (Strides) on Friday said its wholly-owned subsidiaries have entered into definitive agreements with subsidiaries of Endo International plc (Endo) to acquire its manufacturing facility at Chestnut Ridge, New York, for $ 24 million. The new portfolio has 20 commercial products and a basket of dormant ANDAs (abbreviated new drug applications) that are expected to fast track Strides’ new product launch strategy for US markets, as per the communique.More Related News
Air India has signed an agreement with Bengaluru Airport City Limited (BACL), a subsidiary of Bangalore International Airport Limited (BIAL), to develop a built-to-suit facility for the AME program that will feature modern classrooms, well-equipped laboratories for practical training and a team of qualified trainers.